These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 12574425)

  • 61. GABAB receptors in the medial septum/diagonal band slice from 16-25 day rat.
    Henderson Z; Jones GA
    Neuroscience; 2005; 132(3):789-800. PubMed ID: 15837139
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The role of Ca
    Robles Gómez AA; Vega AV; Gónzalez-Sandoval C; Barral J
    Synapse; 2018 Feb; 72(2):. PubMed ID: 29136290
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Endocannabinoid-Specific Impairment in Synaptic Plasticity in Striatum of Huntington's Disease Mouse Model.
    Sepers MD; Smith-Dijak A; LeDue J; Kolodziejczyk K; Mackie K; Raymond LA
    J Neurosci; 2018 Jan; 38(3):544-554. PubMed ID: 29192125
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pathway-Specific Control of Striatal Neuron Vulnerability by Corticostriatal Cannabinoid CB1 Receptors.
    Ruiz-Calvo A; Maroto IB; Bajo-Grañeras R; Chiarlone A; Gaudioso Á; Ferrero JJ; Resel E; Sánchez-Prieto J; Rodríguez-Navarro JA; Marsicano G; Galve-Roperh I; Bellocchio L; Guzmán M
    Cereb Cortex; 2018 Jan; 28(1):307-322. PubMed ID: 29121220
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Spontaneous recurrent network activity in organotypic rat hippocampal slices.
    Mohajerani MH; Cherubini E
    Eur J Neurosci; 2005 Jul; 22(1):107-18. PubMed ID: 16029200
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Altered function of glutamatergic cortico-striatal synapses causes output pathway abnormalities in a chronic model of parkinsonism.
    Warre R; Thiele S; Talwar S; Kamal M; Johnston TH; Wang S; Lam D; Lo C; Khademullah CS; Perera G; Reyes G; Sun XS; Brotchie JM; Nash JE
    Neurobiol Dis; 2011 Mar; 41(3):591-604. PubMed ID: 20971190
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Glutamate hyperexcitability and seizure-like activity throughout the brain and spinal cord upon relief from chronic glutamate receptor blockade in culture.
    Van Den Pol AN; Obrietan K; Belousov A
    Neuroscience; 1996 Oct; 74(3):653-74. PubMed ID: 8884763
    [TBL] [Abstract][Full Text] [Related]  

  • 68. NMDA receptor function in mouse models of Huntington disease.
    Cepeda C; Ariano MA; Calvert CR; Flores-Hernández J; Chandler SH; Leavitt BR; Hayden MR; Levine MS
    J Neurosci Res; 2001 Nov; 66(4):525-39. PubMed ID: 11746372
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Epileptiform activity in the nucleus accumbens induced by GABA(A) receptor antagonists in rat forebrain slices is of cortical origin.
    Buckby LE; Lacey MG
    Exp Brain Res; 2001 Nov; 141(2):146-52. PubMed ID: 11713626
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Functional and molecular development of striatal fast-spiking GABAergic interneurons and their cortical inputs.
    Plotkin JL; Wu N; Chesselet MF; Levine MS
    Eur J Neurosci; 2005 Sep; 22(5):1097-108. PubMed ID: 16176351
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hyperactive striatal neurons in symptomatic Huntington R6/2 mice: variations with behavioral state and repeated ascorbate treatment.
    Rebec GV; Conroy SK; Barton SJ
    Neuroscience; 2006; 137(1):327-36. PubMed ID: 16257492
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Synaptic scaling up in medium spiny neurons of aged BACHD mice: A slow-progression model of Huntington's disease.
    Rocher AB; Gubellini P; Merienne N; Boussicault L; Petit F; Gipchtein P; Jan C; Hantraye P; Brouillet E; Bonvento G
    Neurobiol Dis; 2016 Feb; 86():131-9. PubMed ID: 26626081
    [TBL] [Abstract][Full Text] [Related]  

  • 73. (G2019S) LRRK2 causes early-phase dysfunction of SNpc dopaminergic neurons and impairment of corticostriatal long-term depression in the PD transgenic mouse.
    Chou JS; Chen CY; Chen YL; Weng YH; Yeh TH; Lu CS; Chang YM; Wang HL
    Neurobiol Dis; 2014 Aug; 68():190-9. PubMed ID: 24830390
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis.
    Musella A; Sepman H; Mandolesi G; Gentile A; Fresegna D; Haji N; Conrad A; Lutz B; Maccarrone M; Centonze D
    Neuropharmacology; 2014 Apr; 79():567-72. PubMed ID: 24440366
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Depression of glutamatergic and GABAergic synaptic responses in striatal spiny neurons by stimulation of presynaptic GABAB receptors.
    Nisenbaum ES; Berger TW; Grace AA
    Synapse; 1993 Jul; 14(3):221-42. PubMed ID: 8105549
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Influence of CGS 21680, a selective adenosine A(2A) receptor agonist, on NMDA receptor function and expression in the brain of Huntington's disease mice.
    Ferrante A; Martire A; Armida M; Chiodi V; Pézzola A; Potenza RL; Domenici MR; Popoli P
    Brain Res; 2010 Apr; 1323():184-91. PubMed ID: 20138162
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Inactivation of adenosine A2A receptors reverses working memory deficits at early stages of Huntington's disease models.
    Li W; Silva HB; Real J; Wang YM; Rial D; Li P; Payen MP; Zhou Y; Muller CE; Tomé AR; Cunha RA; Chen JF
    Neurobiol Dis; 2015 Jul; 79():70-80. PubMed ID: 25892655
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: implications for ischemia and Huntington's disease.
    Calabresi P; Centonze D; Pisani A; Sancesario G; Gubellini P; Marfia GA; Bernardi G
    Ann Neurol; 1998 May; 43(5):586-97. PubMed ID: 9585352
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Partial Amelioration of Peripheral and Central Symptoms of Huntington's Disease via Modulation of Lipid Metabolism.
    Chen JY; Tran C; Hwang L; Deng G; Jung ME; Faull KF; Levine MS; Cepeda C
    J Huntingtons Dis; 2016; 5(1):65-81. PubMed ID: 27031732
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Enhanced GABAergic Inputs Contribute to Functional Alterations of Cholinergic Interneurons in the R6/2 Mouse Model of Huntington's Disease.
    Holley SM; Joshi PR; Parievsky A; Galvan L; Chen JY; Fisher YE; Huynh MN; Cepeda C; Levine MS
    eNeuro; 2015; 2(1):. PubMed ID: 26203463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.